Skip to main content
Clinical Trials/NCT03479463
NCT03479463
Terminated
Not Applicable

A Matched Case Clinical Registry - Efficacy of AmnioFix in the Prevention of Post-Operative Salivary Leaks Following Head and Neck Surgery

MiMedx Group, Inc.1 site in 1 country8 target enrollmentMarch 19, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Larynx Cancer
Sponsor
MiMedx Group, Inc.
Enrollment
8
Locations
1
Primary Endpoint
Incidence of Pharayngocutaneous Fistula Development (PCF)
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

This trial aims to determine if intra-operative use of human dehydrated amnion chorion allograft improves post-operative patient healing outcomes.

Detailed Description

This study is to determine if intra-operative use of Amnio-Fix improves post-operative patient healing outcomes after laryngectomy and/or pharyngectomy.

Registry
clinicaltrials.gov
Start Date
March 19, 2018
End Date
March 30, 2019
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject is scheduled to undergo laryngectomy and/or pharyngectomy procedure due to oncological indication
  • Subject is age 18 or older
  • Subject is willing and able to provide informed consent and participate in all procedures and follow-up evaluations necessary to complete the study

Exclusion Criteria

  • Subjects currently enrolled in or planning to enroll in another clinical trial
  • Subjects with a known history of poor compliance with medical treatments
  • Subjects that are using or have used an investigational drug, device, or biologic within the 12 weeks prior to treatment
  • Subjects that have any significant medical condition(s) that, in the opinion of the Investigator, would interfere with protocol evaluation and participation
  • Subject has undergone previous pharyngeal reconstructive surgery
  • Pregnancy at enrollment or within last 6 months, women who are breastfeeding, or women of childbearing potential who are planning to become pregnant during the time of the study OR are unwilling/unable to use acceptable methods of contraception (birth control pills, barriers, or abstinence)

Outcomes

Primary Outcomes

Incidence of Pharayngocutaneous Fistula Development (PCF)

Time Frame: 60 days

Incidence of PCF developement necessitating intervention within the 60 day time point.

Study Sites (1)

Loading locations...

Similar Trials